Jannah Theme License is not validated, Go to the theme options page to validate the license, You need a single license for each domain name.

BYND Cannasoft Enterprises Inc. Begins Beta Testing to Manage Farm CRM Platform at Israel’s Weizmann Institute of Science, The Canadian Business Journal

VANCOUVER, British Columbia, September 28, 2022 (GLOBE NEWSWIRE) — BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) (“BYND” or “Company”) announced that its subsidiary BYND – Beyond Solutions Ltd. has entered into an agreement with the Weizmann Institute for the use of proprietary software. Under the terms of the agreement, the Weizmann Institute of Science will use beta versions of the software provided as SAAS. The beta includes BYND Cannasoft Enterprises’ CRM system – Job management (BENEFIT) and a modular system (CANNASOFT) for managing farms and greenhouses of different crops. BYND Cannasoft Enterprises grants Weizmann Institute permission to use the license free of charge for his one year. The Institute will then have the right to extend the contract and the company will be paid a rate according to the contract.

The Weizmann Institute of Science is one of the world’s leading interdisciplinary basic research institutes in the natural and precision sciences. It is located in Rehovot, Israel, just south of Tel Aviv. It has a long history of research and discovery rooted in its mission to advance science for the benefit of mankind. In parallel, it is educating a significant part of Israel’s scientific leadership and improving science literacy in schools and the general public. The Weizmann Institute of Science pioneered research using CBD to treat conditions as diverse as glaucoma, Parkinson’s disease, side effects of chemotherapy, multiple sclerosis, Crohn’s disease, and CRISPR to better understand cannabis. We use advanced tools such as gene editing.

BYND CEO and Director Yftah Ben Yaackov said: next year. We are honored to have the opportunity to beta test our cloud-based platform at a world-class institution like the Weizmann Institute of Science. ”

BYND Cannasoft Enterprises will carry out updates and continue to develop the software based on the conclusions and applications of customer interactions. BYND Cannasoft expects additional revenue from software license usage and exclusive development for the benefit of the Weizmann Institute of Science.

About the Weizmann Institute of Science

The Weizmann Institute of Science in Israel is one of the world’s top interdisciplinary research institutions. Known for a wide range of explorations in the natural and precision sciences, Weizmann Institute scientists conduct research on the human brain, artificial intelligence, computers and cryptography, astrophysics, and particle physics. I am working on diseases such as Climate change through environmental, marine, and plant science.

About BYND Cannasoft Enterprises Inc.

BYND is an integrated software/cannabis company based in Israel.

CRM software

BYND owns and sells its own Customer Relationship Management (CRM) software product known as “Benefit CRM”. BYND’s Benefit CRM software enables small businesses to optimize their daily operations such as sales management, human resources management, marketing, call center activities and asset management. BYND’s next-generation Benefit CRM platform is now ready for beta testing.

Cannabis CRM

Based on 20 years of experience in CRM software, BYND recently started developing a revolutionary new CRM platform specifically designed to serve the needs of the medical cannabis industry. This new platform is a first in the medical cannabis space and we believe it will transform the industry into a more organized, accessible and price transparent marketplace. The data and information collected through the operation of the Cannabis Farm (see below) and the products it produces will allow BYND to test the new Cannabis CRM Platform and adjust the Platform as necessary. Additionally, operating a cannabis farm and selling medical cannabis will provide additional revenue to further support BYND during the initial rollout period of the Cannabis CRM platform.

cannabis farm

BYND is in the process of securing approval for the transfer of a primary cultivation license to grow medical cannabis in Israel and plans to build a 3.7-acre farm facility near Ashkelon Israel to grow medical cannabis. is. The company’s plans include the construction of four of his state-of-the-art greenhouses, which house approximately 2.5 acres of total growing area. BYND estimates that once the cannabis farm facility is fully operational, it can produce 7,500kg of raw cannabis each year. BYND will also work with strategic partners to develop and market new proprietary cannabis-infused products for sale and export throughout Israel. For more information, see our website www.cannasoft-crm.com, CSE’s website www.thecse.com/en/listings/life-sciences/bynd-cannasoft-enterprises-inc and the information available on SEDAR. please refer to. : www.sedar.com.

Gabi Cabazo
Phone: (604) 833‐6820
Email: [email protected]-crm.com

For media and investor information, please contact:
David L. Kugelman
(866) 692-6847 Toll Free – US and Canada
(404) 281-8556 Mobile and WhatsApp
[email protected]
Skype: Kugusa

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties, and actual results may differ materially from those described. As used in this document, “may”, “could”, “could”, “will”, “intend”, “plan”, “forecast”, “believe ”, “estimate”, “expect” and similar expressions. Such statements reflect our current views regarding future events and are subject to such risks and uncertainties. Many factors could cause actual results to differ materially from the published statements, including factors discussed in filings with Canadian securities regulators and the U.S. Securities and Exchange Commission. If one or more of these risks and uncertainties, such as fluctuations in currency or interest rates, increased competition or general economic or market factors, occurs, or the assumptions underlying the forward-looking statements are not correct, If not, actual results could differ materially from those stated herein. Intended, planned, anticipated, or expected. We disclaim any intention or obligation to update these forward-looking statements, except as required by law. Shareholders are cautioned not to place undue reliance on such forward-looking statements.

Neither the US Securities and Exchange Commission nor the CSE have confirmed, approved or disapproved of the contents of this press release.

CBJ Newsmaker

BYND Cannasoft Enterprises Inc. Begins Beta Testing to Manage Farm CRM Platform at Israel’s Weizmann Institute of Science, The Canadian Business Journal

Source link BYND Cannasoft Enterprises Inc. Begins Beta Testing to Manage Farm CRM Platform at Israel’s Weizmann Institute of Science, The Canadian Business Journal

Related Articles

Back to top button